|
Volumn 169, Issue 4, 2000, Pages 241-244
|
Cost of treating heart failure in an Irish teaching hospital
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANALGESIC AGENT;
ANTIARRHYTHMIC AGENT;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTIDEPRESSANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRONCHODILATING AGENT;
CLOPIDOGREL;
CORTICOSTEROID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DOBUTAMINE;
GASTROINTESTINAL AGENT;
HEPARIN;
LOOP DIURETIC AGENT;
NITRATE;
ORAL ANTIDIABETIC AGENT;
POTASSIUM SPARING DIURETIC AGENT;
SPIRONOLACTONE;
THIAZIDE DIURETIC AGENT;
THYROXINE;
WARFARIN;
ADULT;
AGED;
ARTICLE;
BUDGET;
CARDIOMYOPATHY;
CLINICAL ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
FEMALE;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HEART FAILURE;
HOSPITAL ADMISSION;
HOSPITAL COST;
HUMAN;
HYPERTENSION;
HYPOTHYROIDISM;
IRELAND;
ISCHEMIC HEART DISEASE;
MALE;
PREVALENCE;
TEACHING HOSPITAL;
VALVULAR HEART DISEASE;
WARD;
|
EID: 0034451967
PISSN: 00211265
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03173523 Document Type: Article |
Times cited : (13)
|
References (22)
|